Skip to main content
Erschienen in: Current Diabetes Reports 12/2020

01.12.2020 | Psychosocial Aspects (SS Jaser, Section Editor)

Implementation of Technology-Delivered Diabetes Self-care Interventions in Clinical Care: a Narrative Review

verfasst von: Lyndsay A. Nelson, Sarah E. Williamson, Audriana Nigg, William Martinez

Erschienen in: Current Diabetes Reports | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Evidence is growing for the positive effects of technology-delivered diabetes self-care interventions on behavioral and clinical outcomes. However, our understanding of how to effectively implement these interventions into routine clinical practice is limited. This article provides an overview of the methods and results of studies examining the implementation of technology-delivered diabetes self-care interventions into clinical care. We focus specifically on patient-facing behavioral interventions delivered with technology (e.g., text messaging, apps, websites).

Recent Findings

Eleven articles were included in the review. Most studies (n = 9) examined barriers and facilitators to implementation, while about half (n = 5) integrated the intervention into clinical care and evaluated implementation and/or effectiveness. Only six studies applied a theory or framework. The most common determinants of implementation were time constraints for clinic staff, familiarity with technology, knowledge of the intervention, and perceived value. We found substantial variation in implementation outcomes, including which were reported, how they were assessed, and the results. In the four studies that evaluated effectiveness, hemoglobin A1c improved.

Summary

Successful implementation of technology-delivered interventions has the potential to transform healthcare delivery and improve diabetes health on a population level. Promising strategies to address common determinants of implementation include appointing a clinic champion, developing staff training and educational materials, and adapting intervention processes to the clinic context. Future research should evaluate these implementation strategies to understand when and how they impact outcomes. Frameworks such as Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) can help ensure outcomes are systematically reported and allow for comparison across studies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Morgan JM, Mensa-Wilmot Y, Bowen S-A, Murphy M, Bonner T, Rutledge S, et al. Implementing key drivers for diabetes self-management education and support programs: early outcomes, activities, facilitators, and barriers. Prev Chronic Dis. 2018;15:170399. https://doi.org/10.5888/pcd15.170399.CrossRef Morgan JM, Mensa-Wilmot Y, Bowen S-A, Murphy M, Bonner T, Rutledge S, et al. Implementing key drivers for diabetes self-management education and support programs: early outcomes, activities, facilitators, and barriers. Prev Chronic Dis. 2018;15:170399. https://​doi.​org/​10.​5888/​pcd15.​170399.CrossRef
10.
Zurück zum Zitat Balas EA, Boren SA. Managing clinical knowledge for health care improvement. In: Bemmel J, McCray A, editors. Yearbook of medical informatics 2000: patient-centered systems, vol. 09. Stuttgart: Schattauer; 2000. p. 65–70. Balas EA, Boren SA. Managing clinical knowledge for health care improvement. In: Bemmel J, McCray A, editors. Yearbook of medical informatics 2000: patient-centered systems, vol. 09. Stuttgart: Schattauer; 2000. p. 65–70.
12.
Zurück zum Zitat Nelson LA, Threatt AL, Martinez W, Acuff SW, Mayberry LS. Agile science: what and how in digital diabetes research. In: Klonoff DC, Kerr D, Mulvaney SA, editors. Digital diabetes research. Cambridge: Elsevier Inc.; 2020. Nelson LA, Threatt AL, Martinez W, Acuff SW, Mayberry LS. Agile science: what and how in digital diabetes research. In: Klonoff DC, Kerr D, Mulvaney SA, editors. Digital diabetes research. Cambridge: Elsevier Inc.; 2020.
16.
Zurück zum Zitat Wienert J. Understanding health information technologies as complex interventions with the need for thorough implementation and monitoring to sustain patient safety. Front ICT. 2019;6:9.CrossRef Wienert J. Understanding health information technologies as complex interventions with the need for thorough implementation and monitoring to sustain patient safety. Front ICT. 2019;6:9.CrossRef
19.
Zurück zum Zitat Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. A Product from the ESRC Methods Programme (unpublished report). 2006; University of Lancaster: Institute of Health Research. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. A Product from the ESRC Methods Programme (unpublished report). 2006; University of Lancaster: Institute of Health Research.
47.
Zurück zum Zitat Murray E, Ross J, Pal K, Li J, Dack C, Stevenson F, et al. A web-based self-management programme for people with type 2 diabetes: the HeLP-Diabetes research programme including RCT. Programme Grants Appl Res. 2018;6(5). https://doi.org/10.3310/pgfar06050. Murray E, Ross J, Pal K, Li J, Dack C, Stevenson F, et al. A web-based self-management programme for people with type 2 diabetes: the HeLP-Diabetes research programme including RCT. Programme Grants Appl Res. 2018;6(5). https://​doi.​org/​10.​3310/​pgfar06050.
Metadaten
Titel
Implementation of Technology-Delivered Diabetes Self-care Interventions in Clinical Care: a Narrative Review
verfasst von
Lyndsay A. Nelson
Sarah E. Williamson
Audriana Nigg
William Martinez
Publikationsdatum
01.12.2020
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 12/2020
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-020-01356-2

Weitere Artikel der Ausgabe 12/2020

Current Diabetes Reports 12/2020 Zur Ausgabe

Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)

Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad

Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)

A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes

Pediatric Type 2 and Monogenic Diabetes (O Pinhas-Hamiel, Section Editor)

Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.